| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0069 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |